These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 12491151)
1. Murine models for human immunodeficiency virus type 1-associated dementia: the development of new treatment testing paradigms. Persidsky Y; Gendelman HE J Neurovirol; 2002 Dec; 8 Suppl 2():49-52. PubMed ID: 12491151 [TBL] [Abstract][Full Text] [Related]
2. Macrophage-induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV-1 encephalitis. Poluektova L; Meyer V; Walters L; Paez X; Gendelman HE Glia; 2005 Dec; 52(4):344-53. PubMed ID: 16078235 [TBL] [Abstract][Full Text] [Related]
3. Highly active antiretroviral therapy and human immunodeficiency virus encephalitis. Cook JE; Dasgupta S; Middaugh LD; Terry EC; Gorry PR; Wesselingh SL; Tyor WR Ann Neurol; 2005 Jun; 57(6):795-803. PubMed ID: 15852478 [TBL] [Abstract][Full Text] [Related]
4. Coregistration of quantitative proton magnetic resonance spectroscopic imaging with neuropathological and neurophysiological analyses defines the extent of neuronal impairments in murine human immunodeficiency virus type-1 encephalitis. Nelson JA; Dou H; Ellison B; Uberti M; Xiong H; Anderson E; Mellon M; Gelbard HA; Boska M; Gendelman HE J Neurosci Res; 2005 May; 80(4):562-75. PubMed ID: 15825192 [TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection. Miura Y; Misawa N; Kawano Y; Okada H; Inagaki Y; Yamamoto N; Ito M; Yagita H; Okumura K; Mizusawa H; Koyanagi Y Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2777-82. PubMed ID: 12601160 [TBL] [Abstract][Full Text] [Related]
6. Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. Persidsky Y; Zheng J; Miller D; Gendelman HE J Leukoc Biol; 2000 Sep; 68(3):413-22. PubMed ID: 10985259 [TBL] [Abstract][Full Text] [Related]
7. Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. Poluektova LY; Munn DH; Persidsky Y; Gendelman HE J Immunol; 2002 Apr; 168(8):3941-9. PubMed ID: 11937550 [TBL] [Abstract][Full Text] [Related]
8. Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of Interferon-alpha in the brain. Sas AR; Bimonte-Nelson HA; Tyor WR AIDS; 2007 Oct; 21(16):2151-9. PubMed ID: 18090041 [TBL] [Abstract][Full Text] [Related]
9. Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice. Garaci E; Aquaro S; Lapenta C; Amendola A; Spada M; Covaceuszach S; Perno CF; Belardelli F Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8927-32. PubMed ID: 12853577 [TBL] [Abstract][Full Text] [Related]
10. Molecular biological assessment methods and understanding the course of the HIV infection. Katzenstein TL APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050 [TBL] [Abstract][Full Text] [Related]
11. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Kramer-Hämmerle S; Rothenaigner I; Wolff H; Bell JE; Brack-Werner R Virus Res; 2005 Aug; 111(2):194-213. PubMed ID: 15885841 [TBL] [Abstract][Full Text] [Related]
12. Chimeric toxins targeted to the human immunodeficiency virus type 1 envelope glycoprotein augment the in vivo activity of combination antiretroviral therapy in thy/liv-SCID-Hu mice. Goldstein H; Pettoello-Mantovani M; Bera TK; Pastan IH; Berger EA J Infect Dis; 2000 Mar; 181(3):921-6. PubMed ID: 10720513 [TBL] [Abstract][Full Text] [Related]
13. Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis. Zink WE; Anderson E; Boyle J; Hock L; Rodriguez-Sierra J; Xiong H; Gendelman HE; Persidsky Y J Neurosci; 2002 Mar; 22(6):2096-105. PubMed ID: 11896149 [TBL] [Abstract][Full Text] [Related]
14. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
15. Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis. Anderson ER; Gendelman HE; Xiong H J Neurosci; 2004 Aug; 24(32):7194-8. PubMed ID: 15306653 [TBL] [Abstract][Full Text] [Related]
16. Gene therapy for human immunodeficiency virus infection in the humanized SCID mouse model. Touraine JL; Sanhadji K; Sembeil R Isr Med Assoc J; 2003 Dec; 5(12):863-7. PubMed ID: 14689754 [TBL] [Abstract][Full Text] [Related]
17. An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis. Persidsky Y; Buttini M; Limoges J; Bock P; Gendelman HE J Neurovirol; 1997 Dec; 3(6):401-16. PubMed ID: 9475112 [TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. van Marle G; Henry S; Todoruk T; Sullivan A; Silva C; Rourke SB; Holden J; McArthur JC; Gill MJ; Power C Virology; 2004 Nov; 329(2):302-18. PubMed ID: 15518810 [TBL] [Abstract][Full Text] [Related]
20. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Gray F; Adle-Biassette H; Chretien F; Lorin de la Grandmaison G; Force G; Keohane C Clin Neuropathol; 2001; 20(4):146-55. PubMed ID: 11495003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]